Travere Therapeutics Inc (TVTX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

3611 VALLEY CENTRE DR SAN DIEGO, CA 92130

Travere Therapeutics is a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, the company knows the need for treatment options is urgent - that is why its global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, Travere continuously seeks to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope - today and tomorrow.

Data as of 2021-09-19 12:31:42 -0400
Market Cap1.367 Billion Shares Outstanding60.717 Million Avg 30-day Volume930.427 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-0.51 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.74046 52-week High/Low33.09 / 12.75 Next Earnings Date2021-11-04 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from TVTX instead.

View recent insider trading info

Funds Holding TVTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TVTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

16.1 Thousand total shares from 7 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BRINKLEY RUTH WILLIAMS

  • Director
0 2021-09-14 2

REED ELIZABETH E SVP, GC & CORPORATE SECRETARY

  • Officer
37,548 2021-08-13 11

CLAGUE LAURA CHIEF FINANCIAL OFFICER

  • Officer
31,316 2021-08-13 11

ROSENBERG NOAH L. CHIEF MEDICAL OFFICER

  • Officer
47,614 2021-08-13 9

ROTE WILLIAM E. SENIOR VICE PRESIDENT, R&D

  • Officer
35,731 2021-08-13 11

DUBE ERIC M CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
156,915 2021-08-13 9

HEERMA PETER CHIEF COMMERCIAL OFFICER

  • Officer
63,515 2021-08-13 6

LYONS GARY A

  • Director
46,000 2021-05-14 1

ASELAGE STEVE

  • Director
198,794 2021-05-14 8

COUGHLIN TIMOTHY

  • Director
44,000 2021-05-14 1

SQUARER RON

  • Director
23,875 2021-05-14 1

ORWIN JOHN A

  • Director
23,875 2021-05-14 1

MECKLER JEFFREY A

  • Director
76,000 2021-05-14 1

BRUHN SUZANNE LOUISE

  • Director
17,250 2021-05-14 1

POOLE SANDRA

  • Director
18,500 2021-05-14 1

BAYNES ROY D.

  • Director
26,000 2021-05-14 1

MCFARLANE NEIL F. CHIEF OPERATING OFFICER

  • Officer
26,988 2019-05-15 0

KOZARICH JOHN W

  • Director
29,000 2019-05-08 0

SHIH ALVIN EVP OF RESEARCH & DEVELOPMENT

  • Officer
158,334 2016-09-01 0

GOLDING CORNELIUS E

  • Director
29,000 2016-05-18 0

VALEUR JENSEN MARGARET E GENERAL COUNSEL

  • Officer
100,000 2016-02-01 0

BROADFIN HEALTHCARE MASTER FUND LTD

BROADFIN CAPITAL, LLC

KOTLER KEVIN

  • 10% Owner
2,658,854 2015-01-13 0

PLOTKIN HORACIO CHIEF MEDICAL OFFICER

  • Officer
91,767 2014-12-12 0

RICHARDSON STEVEN GARY

  • Director
129,165 2014-11-21 0

SHKRELI MARTIN

  • FMR OFFICER DIR 10% SHAREHLDR
No longer subject to file 2014-11-14 0

PALEY JEFFREY

  • Director
51,665 2014-08-14 0

PANOFF MARC L CHIEF FINANCIAL OFFICER

  • Officer
221,100 2014-02-24 0

OPALEYE GP LLC

  • 10% Owner
2,097,671 2013-12-24 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

BRINKLEY RUTH WILLIAMS - Director

2021-09-16 18:16:01 -0400 2021-09-14 A 15,750 a 15,750 direct

BRINKLEY RUTH WILLIAMS - Director

2021-09-16 18:16:01 -0400 2021-09-14 A 5,250 a 5,250 direct -1.3772 0.0 1 -1.3772 2

HEERMA PETER - Officer CHIEF COMMERCIAL OFFICER

2021-08-17 19:41:08 -0400 2021-08-17 S 1,407 $17.12 d 63,515 direct -1.142 3.2274 3.2274 6 -1.142 2

REED ELIZABETH E - Officer SVP, GC & CORPORATE SECRETARY

2021-08-17 19:35:36 -0400 2021-08-17 S 1,407 $17.12 d 37,548 direct -1.142 3.2274 3.2274 6 -1.142 2

DUBE ERIC M - Director - Officer CHIEF EXECUTIVE OFFICER

2021-08-17 19:40:12 -0400 2021-08-17 S 7,836 $17.12 d 156,915 direct -1.142 3.2274 3.2274 6 -1.142 2

CLAGUE LAURA - Officer CHIEF FINANCIAL OFFICER

2021-08-17 19:34:43 -0400 2021-08-17 S 1,407 $17.12 d 31,316 direct -1.142 3.2274 3.2274 6 -1.142 2

ROSENBERG NOAH L. - Officer CHIEF MEDICAL OFFICER

2021-08-17 19:39:04 -0400 2021-08-17 S 1,407 $17.12 d 47,614 direct -1.142 3.2274 3.2274 6 -1.142 2

ROTE WILLIAM E. - Officer SENIOR VICE PRESIDENT, R&D

2021-08-17 19:38:13 -0400 2021-08-17 S 1,407 $17.12 d 35,731 direct -1.142 3.2274 3.2274 6 -1.142 2

ROSENBERG NOAH L. - Officer CHIEF MEDICAL OFFICER

2021-08-17 19:39:04 -0400 2021-08-13 A 4,500 a 49,021 direct -1.142 3.2274 3.2274 6 -1.142 2

ROTE WILLIAM E. - Officer SENIOR VICE PRESIDENT, R&D

2021-08-17 19:38:13 -0400 2021-08-13 A 4,500 a 37,138 direct -1.142 3.2274 3.2274 6 -1.142 2

HEERMA PETER - Officer CHIEF COMMERCIAL OFFICER

2021-08-17 19:41:08 -0400 2021-08-13 A 4,500 a 64,922 direct -1.142 3.2274 3.2274 6 -1.142 2

REED ELIZABETH E - Officer SVP, GC & CORPORATE SECRETARY

2021-08-17 19:35:36 -0400 2021-08-13 A 4,500 a 38,955 direct -1.142 3.2274 3.2274 6 -1.142 2

DUBE ERIC M - Director - Officer CHIEF EXECUTIVE OFFICER

2021-08-17 19:40:12 -0400 2021-08-13 A 17,500 a 164,751 direct -1.142 3.2274 3.2274 6 -1.142 2

CLAGUE LAURA - Officer CHIEF FINANCIAL OFFICER

2021-08-17 19:34:43 -0400 2021-08-13 A 4,500 a 32,723 direct -1.142 3.2274 3.2274 6 -1.142 2

ROSENBERG NOAH L. - Officer CHIEF MEDICAL OFFICER

2021-07-29 16:09:24 -0400 2021-07-28 S 1,250 $13.81 d 44,521 direct yes 3.7091 4.8727 73.8182 73.8182 31 0.0 1

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
TRAVERE THERAPEUTICS INC TVTX 2021-09-21 20:45:03 UTC -0.2193 0.2893 1100000
TRAVERE THERAPEUTICS INC TVTX 2021-09-21 20:15:03 UTC -0.2193 0.2893 1100000
TRAVERE THERAPEUTICS INC TVTX 2021-09-21 19:45:03 UTC -0.2193 0.2893 1100000
TRAVERE THERAPEUTICS INC TVTX 2021-09-21 19:15:03 UTC -0.2193 0.2893 1100000
TRAVERE THERAPEUTICS INC TVTX 2021-09-21 18:45:03 UTC -0.2196 0.2896 1100000
TRAVERE THERAPEUTICS INC TVTX 2021-09-21 18:15:03 UTC -0.2196 0.2896 1100000
TRAVERE THERAPEUTICS INC TVTX 2021-09-21 17:45:03 UTC -0.2196 0.2896 1100000
TRAVERE THERAPEUTICS INC TVTX 2021-09-21 17:15:03 UTC -0.2196 0.2896 1100000
TRAVERE THERAPEUTICS INC TVTX 2021-09-21 16:45:03 UTC -0.2198 0.2898 1100000
TRAVERE THERAPEUTICS INC TVTX 2021-09-21 16:15:03 UTC -0.2198 0.2898 1100000
TRAVERE THERAPEUTICS INC TVTX 2021-09-21 15:45:04 UTC -0.2198 0.2898 1100000
TRAVERE THERAPEUTICS INC TVTX 2021-09-21 15:15:04 UTC -0.2198 0.2898 1100000
TRAVERE THERAPEUTICS INC TVTX 2021-09-21 14:45:03 UTC -0.1857 0.2557 1100000
TRAVERE THERAPEUTICS INC TVTX 2021-09-21 14:15:03 UTC -0.1857 0.2557 1100000
TRAVERE THERAPEUTICS INC TVTX 2021-09-21 13:45:03 UTC -0.1857 0.2557 1100000
TRAVERE THERAPEUTICS INC TVTX 2021-09-21 13:15:03 UTC -0.1857 0.2557 1100000
TRAVERE THERAPEUTICS INC TVTX 2021-09-21 12:45:03 UTC -0.1857 0.2557 1100000
TRAVERE THERAPEUTICS INC TVTX 2021-09-20 22:15:03 UTC -0.1857 0.2557 1000000
TRAVERE THERAPEUTICS INC TVTX 2021-09-20 21:45:03 UTC -0.1857 0.2557 1000000
TRAVERE THERAPEUTICS INC TVTX 2021-09-20 21:15:04 UTC -0.1857 0.2557 1000000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Calamos Investment Trust/IL- Calamos Market Neutral Income Fund TVTX -68137.0 shares, $-1684346.64 2021-04-30 N-PORT
Morningstar Funds Trust- Morningstar Alternatives Fund TVTX -6216.0 shares, $-153659.52 2021-04-30 N-PORT
Guidestone Funds- Strategic Alternatives Fund TVTX -4764.0 shares, $-69506.76 2021-06-30 N-PORT
AMERICAN BEACON FUNDS- American Beacon SSI Alternative Income Fund TVTX -11504.0 shares, $-167843.36 2021-06-30 N-PORT
FORUM FUNDS- ABSOLUTE CONVERTIBLE ARBITRAGE FUND TVTX -19800.0 shares, $-288882.0 2021-06-30 N-PORT

Elevate your investments